
Rep. Alexandria Ocasio-Cortez (D-N.Y.) called for Ticketmaster and Live Nation to be broken up on Tuesday as Taylor Swift fans faced highly publicized technical difficulties in obtaining tickets to the singer’s latest tour, reported Bloomberg.
“Daily reminder that Ticketmaster is a monopoly, its merger with LiveNation should never have been approved, and they need to be reigned in. Break them up,” Ocasio-Cortez said in a tweet, without mentioning Swift by name.
The Ticketmaster website appeared to crash or freeze for many fans on Tuesday as they attempted to get tickets to see Swift during a presale. “The Eras Tour” is Swift’s first tour since 2018.
Read more: Ticketmaster Fined $10M For Hacking Rival
Ticketmaster acknowledged the issues, saying in a statement that there was “historically unprecedented demand” for the tickets. The company delayed West Coast pre sales by several hours and delayed a Capital One presale until Wednesday in response.
The ticketing company has faced accusations of anti-competitive behavior as well as complaints about price gouging and excessive fees since it merged with Live Nation in 2010.
Rep. Bill Pascrell (D-N.J.), who attempted to get Swift tickets for his granddaughter, joined Ocasio-Cortez in criticizing the company and urged the Federal Trade Commission and Department of Justice to break up Live Nation and Ticketmaster to “make lots of Swifties and others happy.”
Pascrell was part of a bipartisan group of lawmakers that opposed the merger of Live Nation and Ticketmaster when it came before the Obama administration in 2009. The congressman has repeatedly called for the companies to be broken up since then.
Featured News
Fortnite Returns to Apple’s U.S. App Store After Five-Year Ban
May 21, 2025 by
CPI
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas